Replies to post #34037 on Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

The abstract says 8.5% additional ALK patients...

So I was off by 1%, still 12-14% of NSCLC is triple the currently assumed population. Best part, we will have Pfizer, Novartis, and Roche/Chugai handing out flyers to all MD's in no time.

Let's hope Foundation Medicine comes through for us with a best-in-class diagnostic for ALK detection.